Literature DB >> 48299

Myeloma proteins as tumor-specific antigens.

H N Eisen, N Sakato, S J Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 48299

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

1.  Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin.

Authors:  F K Stevenson; E V Elliott; G T Stevenson
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

2.  An experimental immunocytoma model in /LOU/M/Ws1 X CFY/F1 rats: neoplastic cells as targets of the host's immune apparatus.

Authors:  E Puskás; F Uher; J Gergely; H Bazin
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

Review 3.  Active immunotherapy: current state of the art in vaccine approaches for NHL.

Authors:  M Lia Palomba
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

4.  In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. III. Spontaneous and natural cytotoxic effector cells.

Authors:  A G Herbert; G S Le Gros; S Bidawid; J D Watson
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

5.  Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.

Authors:  Paolo Serafini; Stephanie Mgebroff; Kimberly Noonan; Ivan Borrello
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

6.  Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins.

Authors:  Alejandro López-Requena; Oscar R Burrone; Michela Cesco-Gaspere
Journal:  Front Oncol       Date:  2012-11-09       Impact factor: 6.244

7.  Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study.

Authors:  Katy J McCann; Rosemary Godeseth; Lindsey Chudley; Ann Mander; Gianfranco Di Genova; Paul Lloyd-Evans; Jonathan P Kerr; Vladimir B Malykh; Matthew W Jenner; Kim H Orchard; Freda K Stevenson; Christian H Ottensmeier
Journal:  Cancer Immunol Immunother       Date:  2015-05-16       Impact factor: 6.968

8.  Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes.

Authors:  D W Hough; R P Eady; T J Hamblin; F K Stevenson; G T Stevenson
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

Review 9.  Lymphoma Immunotherapy: Current Status.

Authors:  Roberta Zappasodi; Filippo de Braud; Massimo Di Nicola
Journal:  Front Immunol       Date:  2015-09-01       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.